Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
In the context of Axitinib & Renal Cell Carcinoma (RCC), there is an FDA approval and an EMA approval for axitinib in advanced renal cell carcinoma (RCC) (1, 2)
The clinical phase II treatment trial, identified as NCT02579811, demonstrated that individualized dosing of axitinib in patients with metastatic renal cell carcinoma, who had previously been treated with checkpoint inhibitors, did not achieve the predetermined threshold for progression-free survival. However, the data indicate that this personalized titration approach is both…